Note 16 - Capital Stock

12 Months Ended

Jul. 31, 2023

Notes to Financial Statements

Equity [Text Block]

NOTE 16: CAPITAL STOCK

Equity Financing

On May 17, 2021, we filed a Form S-3 shelf registration statement under the United States Securities Act of 1933, as amended (the “Securities Act”), which was declared effective by the SEC on June 1, 2021, providing for the public offer and sale of certain securities of the Company from time to time, at our discretion, of up to an aggregate offering amount of $200 million (the “2021 Shelf”), which included an at-the-market offering agreement prospectus (the “May 2021 ATM Offering”) covering the offering, issuance and sale of up to a maximum offering of $100 million as part of the $200 million under the 2021 Shelf.

On May 14, 2021, we entered into an at-the-market offering agreement (the “2021 ATM Offering Agreement”) with H.C. Wainwright & Co., LLC and certain co-managers (collectively, the “2021 ATM Managers”) as set forth in the 2021 ATM Offering Agreement under which we may, from time to time, sell shares of our common stock having an aggregate offering price of up to $100 million through the 2021 ATM Managers selected by us.

On November 26, 2021, we filed a prospectus supplement to our 2021 Shelf with respect to the continuation of the May 2021 ATM Offering Agreement with the 2021 ATM Managers under which we may, if eligible, from time to time, sell shares of our common stock having an aggregate offering price of up to an additional $100 million for a total of $200 million through the 2021 ATM Managers selected by us (the “November 2021 ATM Offering”; and, collectively with the May 2021 ATM Offering, the “2021 ATM Offering”).

On November 16, 2022, we filed a Form S-3 automatic shelf registration statement under the Securities Act, which became effective upon filing, providing for the public offer and sale of certain securities of the Company from time to time, at our discretion, of an undetermined dollar value of common stock, debt securities, warrants to purchase common stock or debt securities, subscription receipts for and units which include common stock, debt securities, warrants or any combination thereof (the “2022 Shelf”), which included an at-the-market offering agreement prospectus (the “2022 ATM Offering”; and, collectively, with the 2021 ATM Offering, the “ATM Offerings”) covering the offering, issuance and sale of up to a maximum offering of $300 million under the 2022 Shelf.

On November 16, 2022, we entered into an at-the-market offering agreement (the “2022 ATM Offering Agreement”) with H.C. Wainwright & Co., LLC and certain co-managers (collectively, the “2022 ATM Managers”) as set forth in the 2022 ATM Offering Agreement under which we may, from time to time, sell shares of our common stock having an aggregate offering price of up to $300 million through the 2022 ATM Managers selected by us.

During Fiscal 2022, we issued 15,934,606 shares of the Company’s common stock under our ATM Offerings for net cash proceeds of $35,235.

During Fiscal 2023, we issued 15,171,253 shares of the Company’s common stock under our ATM Offerings for net cash proceeds of $58,420.

Subsequent to July 31, 2023, we issued a further 7,010,000 shares of the Company’s common stock under our ATM Offerings for net cash proceeds of $36,217.

Share Purchase Warrants

A continuity schedule of outstanding share purchase warrants as at July 31, 2023, and the changes during the periods, is as follows:

	Number of			Weighted Average
	Warrants			Exercise Price
Balance, July 31, 2020		7,721,981		$	2.03
Issued in connection with September 2020 Offering		6,833,333			1.80
Issued in connection with April 2021 Offering		181,818			4.13
Exercised		(8,240,505	)		1.99
Expired		(1,109,304	)		1.87
Balance, July 31, 2021		5,387,323			1.90
Exercised		(1,771,869	)		1.88
Balance, July 31, 2022		3,615,454			1.92
Issuance of Replacement Warrants (Note 3,15)		4,660,580			2.95
Exercised		(4,359,086	)		1.73
Expired		(59,918	)		1.80
Balance, July 31, 2023		3,857,030		$	3.31

A summary of share purchase warrants outstanding and exercisable as at July 31, 2023 is as follows:

Weighted Average Exercise Price		Number of Warrants Outstanding		Weighted Average Remaining Contractual Life (Years)		Expiry Date
$	3.27		3,675,212		1.11	September 7, 2024
	4.13		181,818		2.68	April 5, 2026
$	3.31		3,857,030		1.18

During Fiscal 2023, Fiscal 2022 and Fiscal 2021, we received cash proceeds totaling $7,554, $3,589 and $3,325, respectively, from the exercise of share purchase warrants.